Fig. 2From: Definitive radiotherapy alone over 60 Gy for patients unfit for combined treatment to stage II-III non-small cell lung cancer: retrospective analysisCause-specific survivals in accordance with local tumor control. The 2- and 3-year cause-specific survival rates were 56 % and 45 %, respectively, in patients in whom the primary tumor was controlled, and 32 % and 23 %, respectively, in those patients with local failure (P = 0.02)Back to article page